Clinical Trial

Safety, Tolerability, and Distribution of Laquinimod Eye Drops : The LION Study

Study acronym: LION
Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated May 14, 2025 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
The LION Study is a prospective, single-center phase 1 clinical trial to evaluate the safety, tolerability, and distribution of Laquinimod administered as topical eye drops for two weeks in human participants.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-11-29; most recent amendment 2025-05-12.
Status change: Not Yet Recruiting → Recruiting 2024-03-27
Trial Details
NCT Number NCT06161415
Lead Sponsor Quan Dong Nguyen
Collaborators: Global Ophthalmic Research Center (GORC)
Conditions Inflammation, Uveitis
Enrollment 12 participants
Start Date 2024-05-03
Primary Completion 2025-07 (estimated)
Study Completion 2025-07 (estimated)
Updated on ClinicalTrials.gov 2025-05-14